A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
Clinical trial NCT02222493 · COMPLETED
Trial details
- NCT number
- NCT02222493
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-26
- Primary completion
- 2016-06-29
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.